Economic Evaluation of Cannabinoid Oil for Dravet Syndrome: A Cost-Utility Analysis
Abstract
Cannabinoid oils are being increasingly used to treat Dravet syndrome, yet the long-term costs and outcomes of this approach are unknown. Thus, we examined the cost effectiveness of cannabinoid oil as an adjunctive treatment (added to clobazam and valproate), compared with adjunctive stiripentol or with clobazam and valproate alone, for the treatment of Dravet syndrome in children. We performed a probabilistic cost-utility analysis from the...
Paper Details
Title
Economic Evaluation of Cannabinoid Oil for Dravet Syndrome: A Cost-Utility Analysis
Published Date
May 14, 2020
Journal
Volume
38
Issue
9
Pages
971 - 980
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History